+373 (22) 870-971

Contul meu
Ofertă pentruHydroxycarbamidum/ Hydroxycarbamide 500 mg
Date procedură de achiziție
ID procedură
ocds-b3wdp1-MD-1682421570591-EV-1682423097438
Titlu
“Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2023 (repetat nr. 6)”
Beneficiar
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
Descriere
“Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2023 (repetat nr. 6)”
Valoare achiziție
335,474.08 MDL
Perioadă de depunere oferte
2023-05-02 07:00:00 - 2023-05-05 11:00:00
Ofertă
Lot
Obiect achiziție
Valoare lot
Valuta
Valoare ofertă, fără TVA
Hydroxycarbamidum/ Hydroxycarbamide 500 mg
Hydroxycarbamidum/ Hydroxycarbamide 500 mg
Publicată la data: 05/05/2023 13:54
Documente
DataNumeTipReferințaDescriereLimba
08/05/2023 15:33duaesigned.pdfDoc. de eligibilitate (DUAE)Hydroxycarbamidum/ Hydroxycarbamide 500 mgduaesigned.pdfRomana
08/05/2023 15:33garantiapentruofertasigned.pdfGaranțiiHydroxycarbamidum/ Hydroxycarbamide 500 mggarantiapentruofertasigned.pdfRomana
10/05/2023 17:46specificatiitehnicesigned.pdfPropunere tehnicăHydroxycarbamidum/ Hydroxycarbamide 500 mgspecificatiitehnicesigned.pdfRomana
10/05/2023 17:46cereredeparticiparesigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgcereredeparticiparesigned.pdfRomana
10/05/2023 17:46certificatdeinregistrareaintreprinderiisigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgcertificatdeinregistrareaintreprinderiisigned.pdfRomana
10/05/2023 17:46certificatdespreexistentaconturilorbancare(eximbankmdl)signed.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgcertificatdespreexistentaconturilorbancare(eximbankmdl)signed.pdfRomana
10/05/2023 17:46certificatprivindlipsarestantelorfatadebugetul(pinala20230520)signed.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgcertificatprivindlipsarestantelorfatadebugetul(pinala20230520)signed.pdfRomana
10/05/2023 17:46declaratieprivindvalabilitateaoferteisigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgdeclaratieprivindvalabilitateaoferteisigned.pdfRomana
10/05/2023 17:46declarațiesigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgdeclarațiesigned.pdfRomana
10/05/2023 17:46extrasdinregistruldestatalpersoanelorjuridicedin23112022signed.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgextrasdinregistruldestatalpersoanelorjuridicedin23112022signed.pdfRomana
10/05/2023 17:46licentapentruactivitateafarmaceuticasigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mglicentapentruactivitateafarmaceuticasigned.pdfRomana
10/05/2023 17:46listafondatorilorsigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mglistafondatorilorsigned.pdfRomana
10/05/2023 17:46raportfinanciarpentruanul2021signed.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgraportfinanciarpentruanul2021signed.pdfRomana
10/05/2023 17:46specificatiidepretsigned.pdfPropunere financiarăHydroxycarbamidum/ Hydroxycarbamide 500 mgspecificatiidepretsigned.pdfRomana
10/05/2023 17:46Доверенность3от02112020vladchitic(directorexecutiv)signedsigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mgДоверенность3от02112020vladchitic(directorexecutiv)signedsigned.pdfRomana
10/05/2023 17:46lot2-globela-coppsigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mglot2-globela-coppsigned.pdfRomana
10/05/2023 17:46lot2,3-globela-eudragmpsigned.pdfDoc. de calificareHydroxycarbamidum/ Hydroxycarbamide 500 mglot2,3-globela-eudragmpsigned.pdfRomana